Skip to main content

Akari Therapeutics Plc

AKTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001541157

No open-market purchases or sales by Akari Therapeutics Plc insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $1.54M in total; no superinvestor holds it.

13F holders, Q2 2026

Institutional positions in Akari Therapeutics Plc as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
9
+3 vs. Q1 2026
Shares held
150.0K
+83.1K (+124.1%) vs. Q1 2026
Total value
$1.54M
+$1.23M (+398.3%) vs. Q1 2026
New holders
5
1 more added
Sold out
2
1 more reduced

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting AKTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 9 institutions
Q1 2021: 15 institutionsQ2 2021: 12 institutionsQ3 2021: 14 institutionsQ4 2021: 11 institutionsQ1 2022: 11 institutionsQ2 2022: 14 institutionsQ3 2022: 14 institutionsQ4 2022: 15 institutionsQ1 2023: 12 institutionsQ2 2023: 16 institutionsQ3 2023: 8 institutionsQ4 2023: 9 institutionsQ1 2024: 8 institutionsQ2 2024: 10 institutionsQ3 2024: 10 institutionsQ4 2024: 14 institutionsQ1 2025: 11 institutionsQ2 2025: 15 institutionsQ3 2025: 16 institutionsQ4 2025: 21 institutionsQ1 2026: 6 institutionsQ2 2026: 9 institutions
Value heldQ2 2026: $1.54M
Q1 2021: $3.90MQ2 2021: $2.27MQ3 2021: $1.99MQ4 2021: $2.16MQ1 2022: $1.89MQ2 2022: $1.68MQ3 2022: $6.37MQ4 2022: $4.19MQ1 2023: $1.84MQ2 2023: $1.71MQ3 2023: $1.19MQ4 2023: $891.6KQ1 2024: $326.3KQ2 2024: $488.1KQ3 2024: $535.9KQ4 2024: $393.8KQ1 2025: $377.3KQ2 2025: $644.3KQ3 2025: $1.18MQ4 2025: $1.29MQ1 2026: $308.2KQ2 2026: $1.54M
Institutions holding AKTX and their total value by quarter
QuarterHoldersValue
Q2 20269$1.54M
Q1 20266$308.2K
Q4 202521$1.29M
Q3 202516$1.18M
Q2 202515$644.3K
Q1 202511$377.3K
Q4 202414$393.8K
Q3 202410$535.9K
Q2 202410$488.1K
Q1 20248$326.3K
Q4 20239$891.6K
Q3 20238$1.19M
Q2 202316$1.71M
Q1 202312$1.84M
Q4 202215$4.19M
Q3 202214$6.37M
Q2 202214$1.68M
Q1 202211$1.89M
Q4 202111$2.16M
Q3 202114$1.99M
Q2 202112$2.27M
Q1 202115$3.90M

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding Akari Therapeutics Plc; share changes are against Q1 2026.

Institutions holding AKTX in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
MMCAP International Inc. SPC100,000$1.02M0.09%+100,000New
Cresset Asset Management, LLC20,561$210.6K0.00%00.0%Unchanged
Jane Street Group, LLC15,463$158.4K0.00%+15,463New
HRT Financial LP13,745$140.0K0.00%+13,745New
IFP Advisors, Inc181$1.85K0.00%−7,250−97.6%Reduced
SBI Securities Co., Ltd.14$1430.00%+9+180.0%Added
Caitong International Asset Management Co., Ltd8$820.00%+8New
Northwestern Mutual Wealth Management Co7$720.00%+7New
Truvestments Capital LLC1$100.00%00.0%Unchanged
Armistice Capital, LLC0$00.00%−38,922−100.0%Sold out
Morgan Stanley0$00.00%−1−100.0%Sold out